Literature DB >> 6467687

Heterogeneity of human eosinophils. II. Variability of respiratory burst activity related to cell density.

L Prin, J Charon, M Capron, P Gosset, H Taelman, A B Tonnel, A Capron.   

Abstract

Recent work has suggested that there may be heterogeneity amongst human eosinophils. In order to study this further, blood and tissue eosinophils were separated by density gradient centrifugation in discontinuous gradients of metrizamide. Blood eosinophils were obtained from 16 patients with blood eosinophil counts above 1 X 10(9)/l. Resident eosinophils were isolated from alveolar fluid in three of these patients and from pleural effusion in two others. A large proportion of the eosinophils in these patients were of light buoyant density (hypodense) and a high percentage of these showed morphological evidence of hypogranulation. Hypodense eosinophils had a reduced capacity to reduce nitroblue tetrazolium or develop chemiluminescence after stimulation with phorbol myristate acetate. It was concluded that there is structural and metabolic heterogeneity amongst blood and tissue eosinophils in patients with a variety of eosinophilic disorders.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6467687      PMCID: PMC1536255     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Endomyocardial disease and eosinophilia. Report of a case.

Authors:  B E Jaski; E J Goetzl; J W Said; M C Fishbein
Journal:  Circulation       Date:  1978-04       Impact factor: 29.690

2.  Studies on blood eosinophils. II. Patients with Löffler's cardiomyopathy.

Authors:  C J Spry; P C Tai
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

3.  Eosinophil kinetics in two patients with eosinophilia.

Authors:  J C Herion; R M Glasser; R I Walker; J G Palmer
Journal:  Blood       Date:  1970-09       Impact factor: 22.113

4.  Serum decay and placental transport of a mutant mouse myeloma immunoglobulin with defective polypeptide and oligosaccharide structure.

Authors:  S Weitzman; L Palmer; M Grennon
Journal:  J Immunol       Date:  1979-01       Impact factor: 5.422

5.  Eosinophil-mediated mammalian tumor cell cytotoxicity: role of the peroxidase system.

Authors:  E C Jong; S J Klebanoff
Journal:  J Immunol       Date:  1980-04       Impact factor: 5.422

6.  Comparison of human eosinophils from normals and patients with eosinophilia.

Authors:  D A Bass; W H Grover; J C Lewis; P Szejda; L R DeChatelet; C E McCall
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

7.  Role of IgE receptors in effector function of human eosinophils.

Authors:  M Capron; H L Spiegelberg; L Prin; H Bennich; A E Butterworth; R J Pierce; M A Ouaissi; A Capron
Journal:  J Immunol       Date:  1984-01       Impact factor: 5.422

8.  Enhanced helminthotoxic capacity of eosinophils from patients with eosinophilia.

Authors:  J R David; M A Vadas; A E Butterworth; P A de Brito; E M Carvalho; R A David; J C Bina; Z A Andrade
Journal:  N Engl J Med       Date:  1980-11-13       Impact factor: 91.245

9.  Chemiluminescence and superoxide production by myeloperoxidase-deficient leukocytes.

Authors:  H Rosen; S J Klebanoff
Journal:  J Clin Invest       Date:  1976-07       Impact factor: 14.808

10.  The effects of an ECF-A and formyl methionyl chemotactic peptides on oxidative metabolism of human eosinophils and neutrophils.

Authors:  P H Beswick; A B Kay
Journal:  Clin Exp Immunol       Date:  1981-02       Impact factor: 4.330

View more
  24 in total

Review 1.  The role of eosinophils in asthma.

Authors:  C Kroegel
Journal:  Lung       Date:  1990       Impact factor: 2.584

Review 2.  The IgE receptor of eosinophils.

Authors:  M Capron; L Prin
Journal:  Springer Semin Immunopathol       Date:  1990

Review 3.  Eosinophils. Assays and interpretation.

Authors:  D E Maddox
Journal:  Clin Rev Allergy       Date:  1988

4.  Density heterogeneity of eosinophil leucocytes: induction of hypodense eosinophils by platelet-activating factor.

Authors:  T Yukawa; C Kroegel; P Evans; T Fukuda; K F Chung; P J Barnes
Journal:  Immunology       Date:  1989-09       Impact factor: 7.397

5.  The effects of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF) and interleukin-3 on the secretory capacity of human blood eosinophils.

Authors:  P C Tai; C J Spry
Journal:  Clin Exp Immunol       Date:  1990-06       Impact factor: 4.330

6.  A morphometric study of normodense and hypodense human eosinophils that are derived in vivo and in vitro.

Authors:  J P Caulfield; A Hein; M E Rothenberg; W F Owen; R J Soberman; R L Stevens; K F Austen
Journal:  Am J Pathol       Date:  1990-07       Impact factor: 4.307

Review 7.  Eosinophils as effector cells in immunity and hypersensitivity disorders.

Authors:  A B Kay
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

8.  Alteration in the density, morphology, and biological properties of eosinophils produced by bullous pemphigoid blister fluid.

Authors:  M Miyasato; S Tsuda; M Kasada; K Iryo; Y Sasai
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

9.  Presence of factors chemotactic for granulocytes in hypereosinophilic syndrome sera: relation with alterations in eosinophil migration.

Authors:  P Gosset; L Prin; M Capron; C Auriault; A B Tonnel; A Capron
Journal:  Clin Exp Immunol       Date:  1986-09       Impact factor: 4.330

10.  Antigen challenge induces pulmonary airway eosinophil accumulation and airway hyperreactivity in sensitized guinea-pigs: the effect of anti-asthma drugs.

Authors:  S Sanjar; S Aoki; A Kristersson; D Smith; J Morley
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.